Targeting insulin‐like growth factor‐1 receptor (IGF1R) for brain delivery of biologics

The blood‐brain barrier (BBB) prevents the majority of drugs from crossing into the brain and reaching neurons. To overcome this challenge, safe and non‐invasive technologies targeting receptor‐mediated pathways have been developed. In this study, three single‐domain antibodies (sdAbs; IGF1R3, IGF1R...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The FASEB journal Ročník 36; číslo 3; s. e22208 - n/a
Hlavní autori:	Alata, Wael, Yogi, Alvaro, Brunette, Eric, Delaney, Christie E., Faassen, Henk, Hussack, Greg, Iqbal, Umar, Kemmerich, Kristin, Haqqani, Arsalan S., Moreno, Maria J., Stanimirovic, Danica B.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.03.2022
Predmet:	Animals Blood-Brain Barrier - metabolism blood‐brain barrier Capillary Permeability Cell Line Cells, Cultured galanin in situ brain perfusion inflammatory pain insulin growth factor 1 receptor Male Mice Mice, Inbred BALB C Rats Rats, Sprague-Dawley Receptor, IGF Type 1 - immunology receptor‐mediated transcytosis Single-Chain Antibodies - immunology Single-Chain Antibodies - pharmacokinetics blood-brain barrier inflammatory pain galanin in situ brain perfusion insulin growth factor 1 receptor receptor-mediated transcytosis
ISSN:	0892-6638, 1530-6860, 1530-6860
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!